Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by FredTheVoiceon Apr 18, 2018 5:33pm
190 Views
Post# 27907426

La caisse de dépôt et placement du Québec - TH - and TAIMED

La caisse de dépôt et placement du Québec - TH - and TAIMED
So lyne sold a couple of shares.......and La Caisse did the same thing in 2017.

La Caisse, in a recent publication (april 17, 2018) that I checked for you guys, shows that La caisse is still in TH for 4 313 700 shares (page 132). The number I had in hand last year was
5 263 700. I guess they took a little profit to diversify.

But in that same document, (page 129 - listing all companies were la Caisse is investing), we learn that la Caisse is invested in TAIMED BIOLOGICS: 476 000 shares.

Interesting. But I must say, I'm disappointed that la Caisse sold TH last year with such good news coming. Hope they will buy some this year.

FTV.
Bullboard Posts